throbber
Journal of Peptide Science
`J. Peptide Sci. 4: 449–458 (1998)
`
`Tuning Micelles of a Bioactive Heptapeptide Biosurfactant
`via Extrinsically Induced Conformational Transition of
`Surfactin Assembly
`
`MOHAMAD OSMANa,*, HARALD HØILANDb, HOLM HOLMSENc and YUTAKA ISHIGAMId
`
`a School of Science and Technology (HIS), Ullandhaug, Stavanger, Norway
`b Department of Chemistry, University of Bergen, Bergen, Norway
`c Department of Biochemistry and Molecular Biology, University of Bergen, Bergen, Norway
`d National Institute of Materials and Chemical Research, Tsukuba, Ibaraki, Japan
`
`Received 16 September 1997
`Accepted 31 March 1998
`
`Abstract: We have studied the effects of extrinsic environmental conditions on the conformation of surfactin,
`a heptapeptide biosurfactant from Bacillus subtilis, in aqueous solutions. It has been made clear that
`temperature, pH, Ca2(cid:27) ions and the synthetic nonionic surfactant hepta-ethylene glycol (C12E7) affect the
`conformation of surfactin in aqueous solutions. The b-sheet formation reached a maximum at 40°C both in
`presence and absence of (C12E7) and the nonionic surfactant enhances the b-sheet formation even at 25°C.
`Ca2 (cid:27) induced the formation of a-helices and caused this transition at 0.3 mM with surfactin monomers or
`at 0.5 mM with surfactin micelles, but above these transition concentrations of Ca2(cid:27) b-sheets were
`observed. In micellar solution the b-sheet structure was stabilized at pH values below 7 or upon addition
`of Ca2(cid:27) in concentrations above 0.5 mM. Our results indicated that the bioactive conformation of surfactin
`is most likely the b-sheets when the molecules are assembled in micelles. The b-sheet structure in micelles
`could be retained by tuning the micelles. Surfactin micelles could be tuned in the bioactive conformation by
`manipulating pH, temperature, Ca2(cid:27) or (C12E7) concentrations in surfactin solutions. Our results strongly
`indicated that Ca2(cid:27) and other molecules (such as C12E7) may function as directing templates in the
`assembly and conformation of surfactin in micelles. Thus, we suggest environmental manipulation and
`template-aided micellation (TAM) as a new approach for preparing predesigned micelles, microemulsions or
`micro-spheres for specific application purposes. © 1998 European Peptide Society and John Wiley & Sons,
`Ltd.
`
`Keywords: peptide surfactant; surfactin; conformation; micelles; biosurfactant
`
`INTRODUCTION
`
`Surfactin is a lipopeptide produced by Bacillus sub-
`tilis [1–7] and is abundant in many natural prod-
`ucts such as natto (fermented soy beans) [5,8–11].
`It was fist produced and characterized by Kakinuma
`et al. [1–3]. Since, many analogues have been pro-
`duced and studied [10–14]. Surfactin is a biosur-
`
`Abbreviations: Sf, surfactin; C12E7, heptaethylene glycol.
`
`* Correspondence to: School of Science and Technology (HIS), P.O.
`Box 2557, Ullandhaug, N-4004 Stavanger, Norway.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`CCC 1075–2617:98:070449-10$17.50
`
`factant with a high industrial and commercial
`potential because of its superb surface and interfa-
`cial activity [1,2,15] and because it has a diversity of
`bioactive properties [1–3,8–11,16–22].
`It
`forms
`large micelles at a very low concentration [23] and
`the cmc of the different analogues is of the order
`10(cid:28) 5 M [4,21,23] or less. Surfactin has also shown
`ionophoric and sequestering properties [21,24]. The
`bioactivities of surfactin include: inhibition of blood
`clotting [1–3], haemolytic activity [21], repression of
`cAMP phosphodiesterase [14,16–18], hypocholes-
`terolemic action [22], channel formation in mem-
`branes [25], synergistic antifungal activity when
`
`
`1 of 10
`
`FRESENIUS-KABI, Exh. 1017
`
`(cid:1) (cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:9)(cid:10)(cid:3)(cid:7)(cid:11)(cid:5)(cid:6)(cid:7)(cid:12)(cid:5)(cid:13)(cid:9)(cid:5)(cid:14)(cid:10)(cid:15)(cid:8)(cid:9)(cid:16)(cid:8)(cid:9)(cid:17)(cid:5)(cid:13)(cid:12)(cid:5)(cid:18)(cid:15)(cid:14)(cid:12)(cid:10)(cid:3)(cid:19)(cid:2)(cid:8)(cid:5)(cid:11)(cid:7)(cid:20)(cid:5)(cid:21)(cid:1)(cid:3)(cid:8)(cid:11)(cid:9)(cid:5)(cid:22)(cid:23)(cid:5)(cid:24)(cid:25)(cid:26)(cid:25)(cid:5)(cid:18)(cid:15)(cid:17)(cid:9)(cid:27)(cid:1)
`
`

`
`450
`
`OSMAN ET AL.
`
`combined with iturins [19,20], antibiotic activity
`[3,26], antitumour action [8,9] and anti HIV effects
`[11]. These physicochemical and biological activities
`are most likely related to the mode of molecular
`assembly of surfactin in micelles as well as the
`secondary structure and the conformation of the
`surfactin molecules in the aggregates. The relation
`of the conformation of peptides and their physico-
`chemical properties to their biological actions have
`been reported by many authors [27–33]. It has also
`been observed that peptides adopt multiple confor-
`mation in different environments or under distinct
`conditions in the milieu [34–37].
`The peptide conformation is not directed solely by
`the primary structure of the peptide or its intrinsic
`properties but it is also controlled by the con-
`stituents of the extrinsic environment [34–45]. Pep-
`tide may form ion channels, proteins or undergo
`conformational transitions depending on extrinsic
`templates [39], ion types [38,44], hydrophobicity:hy-
`drophilicity of the environment [43], redox proper-
`ties of
`the environment
`[40],
`types of applied
`solvents [37,42] influence of pH [4] and temperature
`[45]. The importance of the conformation of peptides
`in general and the peptide-biosurfactant systems in
`particular is due to the relation of the conformation
`to the system stability as well as the specificity and
`ability of the peptides to bind to either ligands or
`receptors, and the resulting induced biological ac-
`tions. Although many reports have addressed these
`questions, there are no reports regarding the influ-
`ence of such environmental factors on the secondary
`structure, the conformation and the bioactivity of
`micelles formed by peptide biosurfactants. The in-
`vestigation of the conformation of lipopeptides, par-
`ticularly of peptide biosurfactants,
`is of crucial
`importance for the understanding of their potential
`applications. Systems based on biosurfactants have
`been suggested for use in drug targeting, controlled
`drug release, DDS (drug delivery systems), intelli-
`gent liposomes, transdermal absorbtion treatments
`and biosensors [46]. The effectiveness of such sys-
`tems may depend totally or partly on the correct
`conformation of the peptide biosurfactant molecules
`in the surfactant systems, such as liposomes, mi-
`celles, microemulsions
`and
`lipopeptide-micro-
`spheres. Therefore understanding the behaviour
`and the structural transitions in relation to the
`bioactive conformation of the lipopeptides in these
`surfactant systems, is crucial for designing suitable,
`stable and effective peptide biosurfactant systems.
`We have recently reported on the transition of
`a-helix structure to b-sheets in linear surfactin [47]
`
`and we have also reported on the formation of large
`micelles of cyclic surfactin by b-sheet formation
`[23].
`In the present paper we present our results re-
`garding the effects of the manipulation of the extrin-
`sic environment on the conformation of surfactin
`molecules and we discuss the stabilization of the
`secondary structures as well as the induction of
`conformational transitions which are favoured for
`bioactivity. We finally show the possibility of using
`this approach to tune micelles or prepare other
`micro-structures in surfactant systems of peptide
`biosurfactants where stability and biological efficacy
`can be retained at an optimum level.
`
`MATERIALS AND METHODS
`
`Surfactin was purchased from Wako Pure Chem
`Industries Ltd., Japan. The chemical structure of
`cyclic surfactin samples was ascertained by fast
`atom bombardment mass spectroscopy (FAB-MS)
`reported elsewhere [47]. The base peak, 1036.8 cor-
`responded exactly to the molecular weight of cyclic
`surfactin. The cyclic structure was further con-
`firmed by Furier-transformed Infrared spectroscopic
`(FTIR) measurements, the 1730 cm (cid:28) 1 band indi-
`cated the cyclic structure of the cyclic surfactin.
`All other chemicals were of reagent grade. The
`water used in the measurements was purified by
`passing through an ion exchange resin column,
`followed by distillation in an all quartz distillation
`column filled by tipped glass tubes.
`Phosphate buffered saline (PBS buffer) had the
`following formulation: NaCl 8.0 g, KH2PO4 0.2 g,
`Na2HPO4 1.15 g, KCl 0.2 g, per litre of distilled
`water. The pH was adjusted by 0.1 N HCl or 0.1 N
`NaOH to the desired pH.
`FAB mass spectra were taken by a JEOL HX-100
`double focusing mass spectrometer operated at a
`resolving power of 2000 (10% valley definition).
`About 1 mg of sample was dissolved in 2 ml of
`glycerol:H2O mixture (glycerol:H2O(cid:30)1:10 v:v) on a
`stainless-steel plate. A small amount of 1 N HCl was
`added for the measurement of positive ion spectra.
`Samples were bombarded with a xenon atomic beam
`of 6 keV. Data acquisition and processing were
`performed using JEOL JMADA 5000 system.
`FT-JR spectroscopy was performed on surfactin
`using KBr disks. The FT-JR spectra were measured
`using a JASCO FT-IR-5000 spectrophotometer and
`data were acquired and processed using JASCO-
`5000 software, version 2.2.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`2 of 10
`
`

`
`The CD spectra were measured using a JASCO J
`600 polarimeter and the data were acquired and
`processed using the J-600 software, version 2a. The
`spectra obtained were reasonably reproducible by
`repeated measurement under the forced experimen-
`tal conditions.
`The effect of temperature on the conformation of
`surfactin micelles both in the presence and absence
`of
`the nonionic surfactant Heptaethylene glycol
`(C12E7) were performed in 0.1 M NaHCO3 solutions
`having a pH of 8.7. In absence of C12E7 the sur-
`factin concentrations ranged from 1 to 3 mM and in
`the presence of C12E7 the surfactin concentrations
`ranged from 0.25 to 1 mM.
`The effect of temperature and C12E7 addition on
`weight-average (Mw) of surfactin micelles and the
`aggregation number was obtained in the manner
`described elsewhere [23].
`The CD spectra were obtained under strictly con-
`trolled temperatures in the range of 90.1°C. The
`CD spectra were taken in the temperatures range
`25–55°C. The effect of C12E7 on the conformation at
`different temperatures was measured in surfactin
`solutions having a concentration in the range 0.25–
`1 mM and the ratios of surfactin:C12E7 were either
`50:50 or 25:75.
`The molar elipticity (u) values whenever necessary
`were obtained directly from the CD spectra pro-
`cessed by the computer using the software men-
`tioned above.
`Effects of pH on the conformation were performed
`on a series of surfactin solutions in PBS buffer
`where pH values ranged from 6 to 9. A concentra-
`tion of 1(cid:29)l0(cid:28) 6 M, which is 1:10 of surfactin’s cmc,
`was used to examine the effects of pH on the confor-
`mation of surfactin in monomeric form. A concen-
`tration of 2(cid:29)10(cid:28) 5 M, which is twice the cmc of
`surfactin, was used to examine the effects of pH on
`the conformation of surfactin molecules in the mi-
`cellar form. Effects of pH on conformation were
`measured at 25°C.
`The effect of Ca2(cid:27) on the conformation was per-
`formed on a series of surfactin solutions in Tris
`buffer having a pH of 7.5. The concentrations of
`Ca2(cid:27) ranged from 0.1 0.7 mM.
`
`RESULTS AND DISCUSSION
`
`b-Turns and the Secondary Structure of Cyclic
`Peptides
`
`Cyclic peptides have been often used as a model
`
`TUNING MICELLES OF A PEPTIDE BIOSURFACTANT
`
`451
`
`studying b-turn conformation [48]. Since
`for
`surfactin is a cyclic peptide and CD spectra given
`later on may be confused with b-turn configura-
`tion, we do feel it necessary to address the ques-
`tion of b-turn. The b-turn configuration is also
`an important constituent of many proteins, where
`the polypeptide chain abides a relatively reversal
`turn in direction [49,50]. The spectrum of most
`common b-turn structures have a negative band
`near 225 nm, a very strong negative band at
`180–190 nm and a strong positive maximum at
`200–205 nm. There is noticeable difference of
`5–10 nm red shift between the maxima of b-turn
`and b-sheet spectra. However,
`in some special
`cases resemblance to a-helix have been observed,
`where the spectrum has negative bands near 220
`nm and 210 nm and a positive band near 190
`nm. The deviation in such cases is of few nano-
`metres and is not very distinct. The theoretical
`calculations have demonstrated that no single
`CD spectra could be assigned to the structural
`conformation called b-turn [51]. In cyclic peptides,
`the b-turn conformation may look like either a
`b-sheet or a-helix configuration. However, X-ray
`diffraction and NMR are used to substantiate
`such structures in cyclic peptides [52,53].
`In
`addition the configuration in the cyclic structure
`is restricted by the structural bonds and any
`possible b-turn is very specific and can not be
`altered unless the cyclic structure itself
`is de-
`structed.
`The explanatory remarks mentioned above could
`be summarized in the following points:
`
`– No single CD spectra could be attributed to the
`conformation designate b-turn [51].
`– Possible b-turn configuration in cyclic peptides
`such as surfactin need X-ray diffraction and NMR
`for corroboration [52,53].
`– Any possible b-turn in a cyclic peptide is definite
`and will not transform unless the cyclic structure
`is wrecked.
`
`the surfactin
`Since the cyclic structure of
`molecule was maintained all the time under the
`experimental conditions, then the observed gradual
`alterations in the CD spectra of surfactin that are
`described later on in this paper are related to the
`aggregational behaviour of surfactin and could not
`be associated with the possible b-turn configura-
`tion attributed to the cyclic structure of the sur-
`factin molecule.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`3 of 10
`
`

`
`452
`
`OSMAN ET AL.
`
`Effect of the Nonionic Surfactant (C12E7) on the
`Assembly, Conformation and Micellation of Surfactin
`Molecules
`
`Reports by other authors suggest that the addition
`of synthetic surfactants to a peptide solution induce
`conformational transitions in their secondary struc-
`ture [34,54,55]. However, little is known about the
`synthetic surfactants as enhancers or stabilisers of
`defined micellar conformation. Since nonionic sur-
`factants are used in a wide range of applications, we
`have therefore tested the effect of the nonionic sur-
`factant heptaethylene glycol (C12E7) as a model for
`this group of surfactants on the secondary struc-
`ture of surfactin micelles. Contrary to our anticipa-
`tion,
`the micellar aggregation number became
`much higher than expected which indicated an en-
`hancement of
`the assembly of surfactin (Sf)
`molecules in b-sheets and an increase in micelle
`formation. The values of micellar weight-average
`and aggregation number were calculated by the
`extrapolation of the Zimm plots obtained from the
`static light scattering measurements [23]. Figure 1
`shows the changes in micellar weight and the aggre-
`gation number at different Sf:C12E7 ratios.
`As is shown the aggregation number was in-
`creased at the Sf:C12E7 molar ratio of 25:75 and the
`aggregation number raised to 144, indicating en-
`hancement of micellation. Taking the u values for
`the molar elipticity shown in Table 1 into consider-
`ation it becomes clear that the C12E7 enhanced the
`formation of micelles by promoting the assembly of
`surfactin molecules in b-sheets even at very low
`surfactin concentrations of 0.75 mM.
`Table 1 shows the increase of the molar elipticity
`value u at the single minima of 218 obtained from
`the CD spectra measurement in the presence and
`absence of C12E7 at different temperatures.
`Surprisingly, the synthetic surfactant C12E7 did
`not induce any conformational transitions but to
`the contrary, it enhanced the formation of b-sheets.
`Table 1 shows that at 25°C the u value is 1.62(cid:29)
`10(cid:28) 7 deg cm2 dmol(cid:28) 1 in the absence of C12E7 for
`the 3 mM surfactin solution, but this value in-
`creased to 1.71(cid:29)10 (cid:28) 7 deg cm2 dmol(cid:28) 1 at the lower
`surfactin concentration (1 mM) when C12E7 was
`added in a 50:50 Sf:C12E7 ratio The u value in-
`to 1.85(cid:29)10(cid:28) 7 deg cm2
`creased even further
`dmol(cid:28) 1, when surfactin concentration was reduced
`to 0 75 mM and C12E7 was added in a 25:75 Sf:
`C12E7 ratio. This indicates that the b-sheets are
`formed even at very low surfactin concentration due
`to the enhancement caused by the addition of the
`
`synthetic surfactant C12E7. These observations may
`be explained by possible intercalation of the non-
`ionic surfactant between surfactin molecules in the
`micelle, where they possibly function as a template
`that directs the assembly of surfactin in b-sheet
`micelles and thus enhances the b-sheet formation.
`
`Effect of Temperature on the Conformation and
`Assembly of Surfactin Molecules
`
`We further studied the effects of temperature eleva-
`tion on the piling of surfactin molecules in the
`micelles, the secondary structure and the formation
`of b-sheet-micelles, both in presence and in ab-
`sence of C12E7. Our observations clearly indicated
`that increasing the temperature enhanced the for-
`mation of b-sheets both in the absence and in the
`presence of the synthetic surfactant. It also showed
`an increase in micelles aggregation as well as in
`their stability.
`
`Figure 1 The changes in micellar weight and the aggrega-
`tion number of surfactin at different Sf:C12E7 ratios and
`the enhancement of b-sheet micellation.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`4 of 10
`
`

`
`Table 1 Molar Elipticity Changes of Surfactin
`
`TUNING MICELLES OF A PEPTIDE BIOSURFACTANT
`
`453
`
`Substance
`
`Surfactin (Sf)
`
`Sf:C12E7 (molar
`ratio 50:50)
`
`Sf:C12E7 (molar
`ratio 25:75)
`
`Concentration of surfactin
`in the solution (mM)
`
`Temperature
`(°C)
`
`Molar ellipticity [u] deg cm2 dmol(cid:28)1
`at 218 nm minima
`
`3
`3
`3
`2
`2
`1
`1
`
`1
`
`1
`0.5
`0.5
`
`0.75
`
`0.75
`0.5
`0.5
`0.25
`0.25
`
`25
`40
`55
`25
`40
`25
`40
`
`25
`
`40
`25
`40
`
`25
`
`40
`25
`40
`25
`40
`
`1.62(cid:29)107
`1.71(cid:29)107
`1.83(cid:29)107
`2.04(cid:29)107
`2.08(cid:29)107
`1.80(cid:29)107
`1.86(cid:29)107
`
`1.71(cid:29)107
`
`1.73(cid:29)107
`1.63(cid:29)107
`1.73(cid:29)107
`
`1.85(cid:29)107
`
`1.99(cid:29)107
`1.32(cid:29)107
`1.32(cid:29)107
`1.63(cid:29)107
`1.19(cid:29)107
`
`From the results shown in Table 1 we estimated
`maximal increase of 13% in the b-sheet formation
`due to temperature raise. The maximum enhance-
`ment caused by heating of the surfactin system was
`reached at surfactin concentration of 2 mM and at
`temperature of 40°C in the absence of C12E7. The
`maximum temperature effect on enhancing b-sheet
`formation in presence of C12E7 was reached when
`surfactin concentration was 0.75mM, the Sf:C12E7
`ratio was 25:75 and the temperature was 40°C.
`This micellation enhancement
`induced by in-
`creased temperature is in contradiction to what is
`known in the case of normal surfactants. In surfac-
`tant systems employing normal synthetic surfac-
`tants, heating of the surfactant in the aqueous
`solution leads to the de-micellation of aggregated
`surfactant molecules and increase of the dissocia-
`tion of surfactant molecules and hence formation of
`larger number of monomers in the solution.
`The enhancement of micellation by increased
`temperature for this peptide biosurfactant indicates
`strongly that the micellation:de-micellation (associ-
`ation:dissociation) of peptide surfactants is most
`likely ruled by different kinetics from those conven-
`tionally comprehended and applied in the case of
`normal surfactants. It also clearly indicates that the
`theoretical approaches traditionally applied to ex-
`
`plain the behaviour of normal surfactant systems
`may have feasible difficulties in explaining phenom-
`ena such as the enhancement of micellation by
`heating the surfactant in aqueous solutions.
`
`Effects of pH on the Induction of Conformational
`Transitions
`
`Variation in pH is an easy tool for changing proper-
`ties, structure and behaviour of surfactant systems.
`We have examined the effects of pH on the confor-
`mation of surfactin in both micellar and non-micel-
`lar solutions, as it is depicted in Figure 2A. The
`monomers were examined in solutions of 1(cid:29)10 (cid:28) 6
`M, which corresponds to 1:10 cmc of surfactin, and
`the micelles in solutions of 2(cid:29)10(cid:28) 5 M, which corre-
`sponds to about twice the cmc value. Below the cmc
`the surfactin monomers have an unordered confor-
`mation in alkaline solutions when pH is 8.5 or
`more. The unordered structure is distinguished by
`a CD spectra having a strong minima at 202 nm
`and a maxima around 190 nm. At neutral pH the
`conformation changed to b-sheets with a single
`minima at 220 nm and a maxima at 194 nm. In
`slightly acidic pH (pH 6) the surfactin monomers
`have an a-helical conformation, with two minima at
`203 and a stronger minimal value at 222 and a
`maximal value at about 190 nm.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`5 of 10
`
`

`
`454
`
`OSMAN ET AL.
`
`Figure 2 Effect of pH on the conformation of surfactin molecules in an aqueous solution, as determined by CD. A,
`surfactin monomers; and B, surfactin micelles.
`
`However, different transient conformations were
`observed between pH values shown in Figure 2A.
`This indicated a gradual change from one confor-
`mation to another. The minima around 203 nm and
`222 nm in the CD spectra of these transient struc-
`tures
`indicated that
`the
`surfactin molecules
`adapted a mixed conformation of both b-sheets and
`a-helices where the percentages of each form was
`pH dependent. Thus, the change was gradual and a
`sudden shifting from one form to another was never
`observed. This gradual alteration was most likely
`due to the formation of surfactin clusters (dimers,
`trimers, etc.) by the gradual reduction in pH value.
`Above the cmc the pH effect was quite different. At
`an alkaline pH of 9 or more a-helices were formed.
`These were characterized by a CD spectra having
`two minima at 212 nm and 228 nm as well as
`shoulder minima at 206 and a maxima close to 190
`nm. While at lower pH values of less than 9 and as
`low as pH 6 b-sheets were formed. The CD spectra
`had typically a single minima at 220 and a maxima
`about 195–200 nm. This indicated that normally
`the surfactin micelles would have a b-sheet struc-
`ture when pH conditions are similar to those ob-
`tained under the physiological condition. Figure 2B
`shows the CD spectra of surfactin micelles at differ-
`ent pH values.
`Since surfactin has been shown to be most bioac-
`tive at physiological pH values [8,9,21] and has
`
`adopted the b-sheet conformation under the same
`pH values according to the above results, thus it
`may be concluded that the most favourable bioac-
`tivity would be attained when surfactin micelles
`retain the b-sheet structure. However, this confor-
`mation may be affected by the presence of metal
`ions, where the type and concentration of metal
`ions may enhance or dwindle the assembly in b-
`sheet conformation.
`It may be worth while mentioning that at pH
`values above 9 the cyclic lactone ring of surfactin
`may be cleaved to form linear surfactin in the solu-
`tions stored for relatively longer periods of time
`(data not published), and therefore observations
`above pH 9 may be related to linear surfactin rather
`than to cyclic surfactin [47].
`
`Effect of Ca2(cid:27) on Inducing Conformational
`Transitions in Surfactin
`
`Effects of Ca2(cid:27) and other ions on the restoration or
`repression of the biological activity of surfactin have
`been reported [17,20], and the role of ions in the
`formation of surfactin micelles have also been re-
`ported in the literature [20]. Hosono et.al. [17] ob-
`served an increase in the inhibitory activity of the
`deactivated-surfactin on cAMP phosphodiesterase
`by Ca2(cid:27). Thimon et al. [20] observed that the for-
`mation of surfactin micelles increased the antifun-
`gal activity of
`iturins, but excessive amounts of
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`6 of 10
`
`

`
`TUNING MICELLES OF A PEPTIDE BIOSURFACTANT
`
`455
`
`Figure 3 CD spectra for surfactin monomers and micelles in aqueous solution at different Ca2(cid:27) concentrations and at pH
`of 7.5. A, surfactin monomers; and B, surfactin micelles.
`
`ions decreased the synergism of surfactin
`metal
`interacted with iturins [20]. Yet possible relation-
`ship between ions and the preferred bioconforma-
`tion in surfactin were not examined We have
`investigated the effects of Ca2(cid:27) on the b-sheet con-
`formation of surfactin in both monomeric form (1(cid:29)
`10(cid:28) 6 M solutions) and micellar form (2(cid:29)10 (cid:28) 5 M
`solutions) in aqueous solutions of pH 7.5.
`The transitions induced in the monomers were
`dependent on the concentration of Ca2(cid:27). When the
`Ca2(cid:27) concentration was below 0.3 mM, a-helices
`were formed with two minima at 205 and 225 nm,
`and a maximum around 195 nm. At concentration
`of 0.3 mM the CD showed a strong minimal value at
`198 nm indicating an unordered structure. Such
`strong minima also means that a transition from
`one conformation to another is about to take place.
`At concentrations above 0.3 mM the CD spectra of
`monomeric solution showed a b-sheet conformation
`with a minimal value at 220 nm and a maximal
`value around 190 nm. Figure 3A shows the CD
`spectra for surfactin monomers at the different
`Ca2(cid:27) concentration.
`The transitions observed are likely due to the
`binding of surfactin to Ca2(cid:27) and formation of sur-
`factin clusters.
`The transitions induced by Ca2(cid:27) in surfactin mi-
`celles were totally different from those we observed
`in the monomers. At concentrations below 0.5 mM
`
`a-helical structures were observed, with character-
`istic CD spectra having two minima at 202–206 nm
`and at 222 nm, and a maximal value at 190 nm. At
`a concentration of 0.5 mM Ca2(cid:27) the CD spectra
`showed a strong minimum at 202 nm, indicating an
`unordered structure. This minimum also evidenced
`the start of transition from a-helix to b-sheet struc-
`ture. At concentrations above 0.5 mM, the Ca2 (cid:27)
`ions stabilised the formation of b-sheets with char-
`acteristic CD spectra having a single minimum at
`220 nm and a maximum at 195 nm. Figure 3B
`shows the CD spectra of surfactin micelles at differ-
`ent Ca2(cid:27) concentrations.
`These observations show that the Ca2(cid:27) induces
`a-helical structure both in monomers and in mi-
`celles of surfactin, but at critical concentration
`above 0.3 mM for monomers and above 0.5 mM for
`micelles, Ca2(cid:27) causes a transition to b-sheet
`structure.
`The above observations indicated that calcium
`ions not only affect the conformation of surfactin
`both in monomeric and micellar form, but they also
`induce concentration-dependent transitions. It is
`most likely, that Ca2(cid:27) ions in aqueous solutions of
`surfactin function as templates that direct the clus-
`tering, micellation, aggregation or assembly as well
`as conformation of surfactin molecules, and this
`on the Ca2 (cid:27)
`function is
`quite dependent
`concentration.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`7 of 10
`
`

`
`456
`
`OSMAN ET AL.
`
`A comparison of our present results with those of
`other authors [17,20] suggests that the preferred
`bioactive conformation of surfactin is likely to be
`the b-sheets. This is because surfactin micelles
`retain the b-sheet structure when calcium is added
`in sufficient amounts to reach concentration ratios
`similar to those reported [17] and because the
`bioactivity also was retained when the overall re-
`ported experimental conditions [17,20] were also
`comparable with our forced conditions.
`To conclude this discussion, it should be noted
`that since b-sheet enhancement reached a maxi-
`mum at 40°C, the physiological temperature of 37.5
`would be perfect for the induction of bioactively
`conformed surfactin. And because optimum pH val-
`ues for b-sheet formation is close to the physiologi-
`cal one (pH 7) and due to the possibility of directing,
`stabilising and enhancing the b-sheet formation by
`other molecule such as Ca2(cid:27) or C12E7. Thus, the
`surfactin micelles could be tuned to maintain the
`most biologically active conformation by inducing
`and stabilising the b-sheet as a secondary struc-
`ture. Since pH and temperature under the physio-
`logical conditions are fairly stable, then micelles,
`microspheres or microemulsions of surfactin or
`other peptide biosurfactants could be probably de-
`signed and preconformed in a bioactive form in
`advance, using Ca2(cid:27) or other assembly directing
`molecules. Otherwise the tuning for non-physiologi-
`cal purposes could be controlled by pH manipula-
`tion, exploitation of directing molecules such as
`Ca2(cid:27), temperature or a combination of these.
`According to the above presented results, discus-
`sion and remarks both Ca2(cid:27) and C12E7 are most
`likely functioning as assembly templates that direct
`the micellation, surfactin micelles could be as-
`sumed as biologically active protein, structured by
`template-aided
`aggregation
`or
`template-aided
`molecular assembly. And consequently we may sug-
`gest the use of ions or other suitable templates to
`direct the micellation, preparation of micro-emul-
`sions, or micro-sphere devices. Such a template-as-
`sembled micelles (TAM) approach could be used to
`direct the formation of not only micelles but also
`microemulsions, micro-spheres (of specific size, di-
`mensions and function) and other molecular
`devices of potential industrial application such as
`drug delivery systems (DDS), drug targeting, micel-
`lar catalysis and in many industrial applications. In
`such process metal
`ions could be used as ionic
`templates in an ion-aided micellation (IAM), but
`other molecules specially designed as templates to
`aid formation of micelles or micro emulsions could
`
`be used in a template-aided micellation (TAM)
`approach.
`
`CONCLUSIONS
`
`It has been made clear that the peptide biosurfac-
`tant surfactin does not follow the normal kinetics of
`surfactant aggregation because the micellation was
`enhanced by increasing the temperature. Another
`deviation from the normal kinetics was the en-
`hancement of aggregation by the synthetic surfac-
`tants. Comparing
`our
`results
`regarding
`the
`conformation of surfactin with the conditions used
`by other authors to test the bioactivity of surfactin it
`became clear that the b-sheet micelles were most
`likely the best bioactive form of surfactin. The b-
`sheet conformation could be easily retained by ma-
`nipulation of extrinsic environmental factors such
`as temperature, pH or Ca2(cid:27). There were also strong
`indications that substances such as Ca2(cid:27) and
`C12E7 direct the micellation and function as assem-
`bly templates for the aggregation process. These
`indications were confirmed by the enhancing b-
`sheet micellation as well as micelle stabilization
`using such substances. Due to these observations
`the tuning of micelles either by environmental ma-
`nipulation or by template-aide aggregation (TAM)
`was suggested. This approach could make possible
`the preparation of micelles, microspheres or microe-
`mulsions with specific dimension, function, stabil-
`ity and bioactivity.
`
`REFERENCES
`
`1. K. Arima, A. Kakinuma and G. Tamura (1968). Sur-
`factin, a crystalline surfactant produced by Bacillus
`subtilis: Isolation, characterization and its inhibition of
`fibrin clot formation. Biochem. Biophys. Res. Commun.
`31, 488–494.
`2. A. Kakinuma, G. Tamura and K. Arima (1968). Wetting
`of fibrin plate and apparent promotion of fibrinolysis
`by surfactin, a new bacterial peptidelipid surfactant.
`Separatum Exp. 24, 1120–1121.
`3. A. Kakinuma and K. Arima (1969). Surfactin, a novel
`peptidelipid surfactant produced by Bacillus subtilis
`in: Annual Report of the Takeda Research Laboratories
`28, p. 140–193.
`4. D.G. Cooper, C.R. McDonald, S.J.B. Duff and N.
`Kosaric,
`(1981). Enhanced production of surfactin
`from Bacillus subtilis by continuous product removal
`and metal cation addition. Appl. Environ. Microbiol. 42,
`408–412.
`
`© 1998 European Peptide Society and John Wiley & Sons, Ltd.
`
`J. Peptide Sci. 4: 449–458 (1998)
`
`
`8 of 10
`
`

`
`5. J.D. Sheppard and C.N. Mulligan (1987). The produc-
`tion of surfactin by Bacillus subtilis grown on peat
`hydrolysate. Appl. Microbiol. Biotechnol. 27, 110–116.
`6. C.N. Mulligan and B.F. Gibbs (1990). Recovery of bio-
`surfactants by ultra filtration. J. Chem. Tech. Biotech-
`nol. 47, 23–29.
`7. C. Ullrich, B. Kluge, Z. Palacz and J. Vater (1991).
`Cell-free biosynthesis of surfactin, a cyclic lip

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket